Benzimidazoles Against Certain Breast Cancer Drug Targets: A Review

Mini Rev Med Chem. 2022;22(19):2463-2477. doi: 10.2174/1389557522666220328161217.

Abstract

Background: Benzimidazoles are widely used scaffolds against various types of cancer, including breast cancer. To this end, anticancer agents must be developed using the knowledge of the specific targets of BC.

Objective: In this study, we aim to review the compounds used against some of the biomolecular targets of breast cancer. To this end, we present information about the various targets, with their latest innovative studies.

Conclusion: Benzimidazole ring is an important building block that can target diverse cancer scenarios since it can structurally mimic biomolecules in the human body. Additionally, many studies imply the involvement of this moiety on a plethora of pathways and enzymes related to BC. Herein, our target- based collection of benzimidazole derivatives strongly suggests the utilization of benzimidazole derivatives against BC.

Keywords: Anticancer drugs; benzimidazoles; breast cancer; pathways; plethora of pathways; target-based biomolecules.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Benzimidazoles / pharmacology
  • Benzimidazoles / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / metabolism
  • Female
  • Humans
  • Hypoglycemic Agents
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Benzimidazoles
  • Hypoglycemic Agents